Tilmovet(R) AC (tilmicosin phosphate) When you have choices, you have control. H

AASV Foundation Funded Research: Final Report Available

The AASV Foundation granted $30,000 to Dr Marcelo Almeida and co-investigators to fund the proposal, "Comparison of the pathological and clinical effects of an F18 enterotoxigenic Escherichia coli containing a tia adhesin gene against a contemporary F18 Escherichia coli strain." The project is complete and the final report is available.

The two objectives of the study were to compare the clinical impact and to assess the efficacy of a commercially available F18 E coli competitive exclusion product in controlling postweaning diarrhea caused by an ETEC-F18+/tia+.

This work was presented at the 2023 ISU James D McKean Swine Disease Conference and will be presented as a poster in the Research Topics session of the 2024 AASV Annual Meeting.

Final Report: "Comparison of the pathological and clinical effects of an F18 enterotoxigenic Escherichia coli containing a tia adhesin gene against a contemporary F18 Escherichia coli strain"

View other AASV Foundation funded research updates at aasv.org/foundation/research